Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Triglycerides measurement
|
1418 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.800 | 1.000 | 8 | 2007 | 2019 | ||||
High density lipoprotein measurement
|
1440 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.800 | 1.000 | 5 | 2008 | 2019 | ||||
Coronary heart disease
|
1178 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.710 | 1.000 | 2 | 2011 | 2016 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.710 | 1.000 | 2 | 2018 | 2019 | ||||
Serum HDL cholesterol measurement
|
679 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.700 | 1.000 | 2 | 2008 | 2012 | ||||
Pseudocholinesterase Measurement
|
568 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||
Serum albumin measurement
|
3282 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Serum total cholesterol measurement
|
1243 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||
Coronary Artery Disease
|
1577 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.030 | 1.000 | 3 | 2016 | 2019 | ||||
Metabolic Syndrome X
|
591 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.020 | 0.500 | 2 | 2015 | 2015 | ||||
Alzheimer's Disease
|
1843 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Atherogenic dyslipidaemia
|
9 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Chronic Lymphocytic Leukemia
|
291 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Coronary Arteriosclerosis
|
440 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Coronary Stenosis
|
20 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Hyperlipidemia, Familial Combined
|
28 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Metabolic Diseases
|
50 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Obesity
|
1111 | 0.732 | 0.440 | 8 | 19962213 | stop gained | C/G | snv | 9.2E-02 | 9.0E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 |